Variations In Mortality Risk Among COPD Patients In Clinical Trials: Data From The Uplift Study

被引：0
|
作者：
Burgel, P-R [1 ]
Paillasseur, J-L [2 ]
Dusser, D. [1 ]
Roche, N. [1 ]
Liu, D. [3 ]
Liu, Y. [3 ]
Furtwaengler, A. [3 ]
Metzdorf, N. [3 ]
Decramer, M. [4 ]
机构：
[1] Univ Paris 05, Pulm Unit, Paris, France
[2] Clindatafirst, Clamart, France
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[4] Katholieke Univ Leuven, Leuven, Belgium
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5558
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identifying COPD patients at increased risk of mortality: Predictive value of clinical study baseline data
    Halpin, David M. G.
    Peterson, Stefan
    Larsson, Thomas P.
    Calverley, Peter M. A.
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1615 - 1624
  • [2] Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
    Putcha, Nirupama
    Anzueto, Antonio R.
    Calverley, Peter M. A.
    Celli, Bartolome R.
    Tashkin, Donald P.
    Metzdorf, Norbert
    Mueller, Achim
    Wise, Robert A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (02) : 204 - 213
  • [3] Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial)
    Tashkin, D.
    Celli, B.
    Decramer, M.
    Liu, D.
    Burkhart, D.
    Cassino, C.
    Kesten, S.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 (04) : 584 - 587
  • [4] Principal component analysis of the baseline clinical data from two large COPD trials to understand the associations among measurements on patients with COPD
    Wisniewski, M
    Rickard, K
    Anderson, W
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A815 - A815
  • [5] Evaluation of Clinical Data and Mortality among COPD Patients Receiving Domiciliary NIMV Therapy
    Ornek, Tacettin
    Erboy, Fatma
    Atalay, Figen
    Altinsoy, Bulent
    Tanriverdi, Hakan
    Uygur, Firat
    Tor, Meltem
    TURKISH THORACIC JOURNAL, 2014, 15 (03) : 112 - 116
  • [6] Perplexing mortality data from triple therapy trials in COPD
    Martinez, Fernando J.
    Darken, Patrick
    Dorinsky, Paul
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E96 - E96
  • [7] Perplexing mortality data from triple therapy trials in COPD
    Suissa, Samy
    LANCET RESPIRATORY MEDICINE, 2021, 9 (07): : 684 - 685
  • [8] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
    Singh, Dave
    Wedzicha, Jadwiga A.
    Siddiqui, Salman
    de la Hoz, Alberto
    Xue, Wenqiong
    Magnussen, Helgo
    Miravitlles, Marc
    Chalmers, James D.
    Calverley, Peter M. A.
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [9] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
    Dave Singh
    Jadwiga A. Wedzicha
    Salman Siddiqui
    Alberto de la Hoz
    Wenqiong Xue
    Helgo Magnussen
    Marc Miravitlles
    James D. Chalmers
    Peter M. A. Calverley
    Respiratory Research, 21
  • [10] RECRUITMENT TO COPD CLINICAL TRIALS FROM PRIMARY CARE PATIENTS
    Brill, S. E.
    El-Emir, E.
    Singh, R.
    Patel, A. R. C.
    Mackay, A. J.
    Donaldson, G. C.
    Nazareth, I.
    Wedzicha, J. A.
    THORAX, 2012, 67 : A143 - A144
12345